Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor...
28 insider purchases on record · latest filing 2025-09-09.
Insiders have also filed 72 sale transactions at AXSM.